Amgen - Amgen says obesity drug caused up to 20% weight loss after a year, but shares drop 10% [SnapMato.Me]

Amgen says obesity drug caused up to 20% weight loss after a year, but shares drop 10%	マスコミが伝えないアジアンニュース
Amgen scraps experimental weight loss pill, moves forward with injection	マスコミが伝えないアジアンニュース
Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel criticizes trial	ãããã«ãï½ãï¼

#Amgen